Prognia
Drug Database
🇪🇺EU · EMARefusedATC: B01AF

Dexxience(betrixaban maleate)

Venous Thromboembolism

Marketing Authorisation Holder: Portola Pharma UK Limited

INN: betrixaban

Indication

Prevention of venous thromboembolism

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Dexxience — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.